Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Quality varies, and the safety and accuracy of a compounded medication depends on the pharmacy preparing it
Clinicians typically consider switching to maintenance when a patient has reached approximately 70 to 90 percent of their target weight loss, has maintained a stable weight for 4 to 6 weeks, and has established healthy habits over a 6- to 12-month period
Neither Eli Lilly (the manufacturer of Mounjaro and Zepbound) nor any compounding pharmacy can legally provide oral tirzepatide at this time
In 2025, before the Wegovy pill was approved, the Wegovy injection was approved for treating the liver disease metabolic-associated steatotic hepatitis (MASH)
The encouraging challenge now is to ensure that these gains are sustained through a combination of prevention, healthier lifestyles, equitable access to care, and appropriate use of effective therapies where clinically indicated
US$ 26.68
US$ 23.11
US$ 27.88
